DoD Bone Marrow Failure, Idea Development Award

Active
Yes
Status
Posted
Published Date
June 7th, 2024
Close Date
October 9th, 2024
Total Funding
$4,240,000.00
Expected No. Awards
5
Opportunity No.
HT942524BMFRPIDA

Agency

Dept. of the Army -- USAMRAA (DOD-AMRAA)

Eligible Applicants

Unrestricted

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Summary

The Department of the Army -- USAMRAA has posted a grant opportunity titled "DoD Bone Marrow Failure, Idea Development Award". This grant is in the category of Science and Technology and other Research and Development. The grant does not require cost sharing or matching. The total program funding is estimated to be $4,240,000, with an expected number of 5 awards to be given. The grant is open to unrestricted applicants. The purpose of the BMFRP Idea Development Award (IDA) is to support innovative ideas and high-impact approaches based on scientifically sound evidence to advance the understanding and cure of Bone Marrow Failure (BMF) diseases. This funding opportunity is specifically designed to support new ideas and research studies that have the potential to reveal new avenues of investigation. The proposed research should have a well-formulated, testable hypothesis based on strong scientific rationale and a well-developed research approach. The grant encourages hypothesis-driven correlative studies associated with clinical trials that align with the innovative intent of this award mechanism. If proposing a correlative study, it should be associated with a clinical trial(s) and should contribute to the generation of new hypotheses or advance the understanding of disease biology, treatment mechanisms, or other innovative and impactful outcomes. It is important to note that funding to conduct the clinical trial itself is not included in this funding opportunity. This grant opportunity is open to both Established Investigators (EIs) and Early-Career Investigators (ECIs). ECIs will be assessed using different criteria for personnel during the review process. Regardless of career level, the proposed team should have a strong background in BMF disease research. For more information or assistance, you can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507. The opportunity to apply for this grant will close on October 9, 2024, and the archive date is set for November 8, 2024.

Description

The BMFRP Idea Development Award (IDA) is intended to support innovative ideas and high-impact approaches based on scientifically sound evidence to move toward the BMFRP’s vision of understanding and curing BMF diseases. This award mechanism is designed to support new ideas. Proposed research studies should have a high probability of revealing new avenues of investigation. The research project should include a well-formulated, testable hypothesis based on strong scientific rationale and a well-developed and articulated research approach. Hypothesis-driven correlative studies associated with clinical trials that meet the innovative intent of this award mechanism are encouraged. An application that proposes a correlative study should be associated with a clinical trial(s), and the proposed study should facilitate the generation of new hypotheses or advance the understanding of disease biology, treatment mechanisms, or other innovative and impactful outcomes. Funding to conduct the clinical trial itself is outside the scope of this funding opportunity.This funding opportunity is open to Established Investigators (EIs) and Early-Career Investigators (ECIs). ECIs will be assessed using different criteria for personnel during the review process (refer to Section II.E.1.a, Peer Review). Independent of career level, personnel on the proposed team should have a strong background in BMF disease research.

Contact Information

Attachments
527 KB

Opportunity Lifecycle

Title
Type
Grant

Similar Opportunities

DoD Bone Marrow Failure, Investigator-Initiated Research Award
Dept. of the Army -- USAMRAA
The Department of the Army, through the US Army Medical Research Acquisition Activity (USAMRAA), has posted a grant opportunity titled "DoD Bone Marrow Failure, Investigator-Initiated Research Award". This grant aims to support research in the field of bone marrow failure and offers two funding levels with different intents. Funding Level 1 (FL1) is intended to support studies that further develop mature ideas, expand upon key discoveries, and have the potential to make significant advances in research and/or patient care in the FY24 BMFRP Focus Areas. FL1 awards may involve translational and clinical research, including studies in animal models, research with human data and/or anatomical substances, and research with human subjects. However, FL1 awards may not be used to support a clinical trial. Multidisciplinary collaborations are encouraged. Funding Level 2 (FL2) is aimed at supporting Investigational New Drug (IND) application-enabling efforts. The BMFRP recognizes the challenges associated with advancing promising therapeutic agents from the laboratory to clinical evaluation. FL2 awards require empirical studies focused on the accumulation of data for a lead therapeutic candidate that will be included in an IND application submission to the U.S. Food and Drug Administration (FDA). FL2 applications must address the FY24 BMFRP Focus Area of finding effective treatments and cures for bone marrow failure. The grant opportunity does not require cost sharing or matching and is open to unrestricted applicants. The total program funding is $2,440,000, and it is expected that two awards will be granted. The closing date for applications is October 9, 2024, and the archive date is November 8, 2024. For more information and assistance, interested applicants can contact the CDMRP Help Desk via phone at 301-682-5507 or email at help@eBRAP.org.
DoD Rare Cancers, Idea Development Award
Dept. of the Army -- USAMRAA
The Department of the Army -- USAMRAA has posted a grant opportunity titled "DoD Rare Cancers, Idea Development Award". This grant aims to promote new ideas in the early stages of development that have the potential to yield impactful data and new avenues of investigation for rare cancers. The grant supports research with preliminary data that could lead to critical discoveries or major advancements in eradicating deaths and suffering from rare cancers. The grant encourages innovative research involving nuclear medicine and related techniques to improve diagnosis, treatment, and health outcomes for active-duty Service Members and their Families. It also encourages research on health areas and conditions that affect women uniquely or differently from men. The grant does not allow clinical trials and emphasizes adherence to rigorous study design and reporting standards. Applications from investigators within the military services and collaborations among academia, industry, the military services, the U.S. Department of Veterans Affairs, and other federal government agencies are highly encouraged. The close date for this grant opportunity is September 26, 2024. For more information, contact the CDMRP Help Desk at help@eBRAP.org or 301-682-5507.
DoD Peer Reviewed Cancer, Idea Award
Dept. of the Army -- USAMRAA
The Department of the Army, through the US Army Medical Research Acquisition Activity (USAMRAA), has posted a grant opportunity titled "DoD Peer Reviewed Cancer, Idea Award". This grant aims to support innovative and high-risk concepts, theories, paradigms, and basic cancer research. The funding of $16,000,000 is expected to result in approximately 20 awards. The Idea Award is specifically designed to encourage research that introduces new paradigms, challenges existing ones, and offers highly creative approaches to cancer research. It is not intended to support incremental advances or logical progressions of established projects. The proposed research should have a well-formulated, testable hypothesis based on strong scientific rationale and study design, and generate robust preliminary data. Inclusion of preliminary data is discouraged as this award focuses on exploratory research. Researchers are encouraged to select the most appropriate funding opportunity for their proposed research. For more information, interested applicants can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507. The deadline for submission is September 26, 2024, and the archive date is October 26, 2024.
DOD Duchenne Muscular Dystrophy, Idea Development Award
Dept. of the Army -- USAMRAA
The Department of the Army, through the US Army Medical Research Acquisition Activity (USAMRAA), has posted a grant opportunity titled "DOD Duchenne Muscular Dystrophy, Idea Development Award". This grant aims to promote new ideas in the early stages of development that have the potential to yield impactful data and new avenues of investigation for individuals with Duchenne Muscular Dystrophy (DMD). The grant supports conceptually innovative, high-risk/high-reward research that could lead to critical discoveries or major advancements in improving outcomes for individuals with DMD. The grant encourages applications from independent investigators in the early stages of their careers or established investigators new to DMD research. It also provides separate funding categories for new investigators in the early stage of their faculty appointments and investigators transitioning to a career in DMD. Collaboration with experienced investigators in DMD research is strongly encouraged. Preliminary data relevant to DMD is required to support the feasibility of the research hypotheses and approaches. The grant emphasizes innovation and impact, with a focus on research that challenges current paradigms and has the potential to significantly accelerate progress in improving outcomes for individuals with DMD. Clinical trials are not allowed under this funding opportunity. For more information, interested applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507. The deadline for applications is August 22, 2024.